|
|
|
|
|
|
Built on Altasciences’ end-to-end expertise in drug development, this collection of eBooks, videos, and insights offers perspectives across the clinical continuum—helping you address today’s challenges, support informed decision-making, and advance your programs with confidence.
|
|
|
|
|
Advances in small molecules, biologics, psychedelics, medical devices, and AI are redefining how we treat neurological and psychiatric disorders, while evolving regulations and precision technologies accelerate clinical development. In this presentation, Dr. Beatrice Setnik examines the trends and innovations shaping the next generation of therapies.
|
|
|
|
|
Some psychoactive drugs need to be assessed for their impact on driving ability. Driving simulation studies provide all the data you need for regulatory approval while offering faster startup, reduced costs, and no safety risk compared to on-the-road testing. Learn more and discover a real-life case study.
|
|
|
|
|
As clinical trials become increasingly complex, sponsors require flexible solutions that extend beyond a single-site approach. Explore how multi-center and hybrid clinical trial strategies reduce bottlenecks, improve participant recruitment, and accelerate Phase I–II studies through scalable, global site networks.
|
|
|
|
|
Selecting the right CRO partner is crucial for executing a successful first-in-human study. From IND submission and dose selection to trial design, participant safety, and risk mitigation, discover how Altasciences provides a controlled, data-driven path to meaningful outcomes.
|
|
|
|
|
Partnering with an integrated CRO/CDMO enables flexible GMP compounding and adaptive formulation, helping you respond to emerging data, reduce waste, conserve valuable API, and accelerate cost-effective clinical development. See how your program can benefit!
|
|
|
|
|
|
|
Clinical trials can move fast, but expert oversight ensures they move safely. Learn how Altasciences’ clinical research associates (CRAs) provide rigorous clinical trial monitoring, proactive risk management, and real-time communication across our three pharmacology units, ensuring protocol adherence, patient safety, and high-quality data.
|
|
|
|
|
|
|
Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.
|
|
|
|
|
|
|
Contact us to discuss your drug development needs.
|
|
|
